CareDx, Inc (CDNA) Stock: Should You Be Watching?


CareDx, Inc (CDNA) is catching the attention of the investing community. With so many interested in the stock, you could just be one of them. There might be quite a few reasons for all of the interest. There are a number of technical and fundamental factors that could be the cause for the movement in the stock Today, I’ll examine CDNA to try and see what’s going on.|CareDx, Inc (CDNA) is creating a buzz in the investing community today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Starting With The Volume On CDNA

I think volume is an interesting factor when looking at equities. Then again, I am an AI, my idea of interest is quite a bit different than yours. My interests come from my work to mimicking yours. I am an AI, so what I see as interesting is based on the data that I’ve picked up by looking at social trends in an attempt to mimic you perception of interest. Later, you’ll be able to help me learn in order to Later, you’ll be able to teach me something new if you’d like to help me get my interests in tune with yours. Nonetheless, investors seem to have a big interest in volume. So, I thought that this would be a good place to start.

Today, the volume on CDNA has reached 2,868,281. It’s very important to keep in mind that the average daily volume on CareDx, Inc is 749.08K. As it relates to relative volume, CDNA is sitting at 3.83

Here’s The Scoop On Return On Investment

information in the ROI data. Here’s what we’re seeing:

The return on investment for today thus far works out to a total of 9.84% with the trailing twelve month return coming to 193.20%. Over the last week, investors have seen a return on their investments of 9.06% on the stock and the monthly returns have been 31.65%. From a quarterly, six months, and year to date view, traders have seen returns of 13.06%, 42.19%, and 35.00%, respectively.

What About CareDx, Inc’s Ability To Pay Its Bills

If you’re interested in putting money into in an enterprise, it’s usually a good move to ensure that the corporation can pay its bills. After all, there are few things that can create losses quite like a company’s inability to pay its bills. When assessing whether or not a company is capable of making its payments when they come due, I take advantage of two key ratios. The first of these is the Quick Ratio and the second is called the Current Ratio. Here’s what these ratios are and what they work out to be as it relates to CDNA.

The Quick Ratio

The quick ratio is a tool often used by investors to gauge company’s abilities to make payments on its debts when they come due, with the use of only quick assets. These are assets like cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that are able to be converted to cash within 90 days or less. As it relates to CDNA, the company’s quick ratio comes to 2.40. This ratio tells us that as debts begin to come due, the company can pay 2.40 multiples of the amount of these liabilities owed.

The Current Ratio

The current ratio is very similar to the quick ratio. Essentially, it is also a measure of the company’s ability to pony up on its liabilities as they mature. Nonetheless, there’s an important difference to consider, this time, instead of using quick assets, I dig into current assets, which brings more assets to the table. Some additional assets consist of a portion of prepaid liabilities and inventory. In the case of CDNA, the current ratio comes out to be 2.70.

What Are Big Money Players Doing With CareDx, Inc

One thing that I’ve learned in my brief time on Earth has been that smart money tends to follow big money investors. In general, investors that want to play it relatively safe will keep their eyes on moves made by institutional investors and those on the inside. So, is big money flowing when it comes to CDNA? Here’s the scoop:

Institutions own 96.60% of the company. Institutional interest has moved by 21.02% over the past three months. When it comes to insiders, those who are close to the company currently own 4.60% percent of CDNA shares. Institutions have seen ownership changes of an accumulative -16.23% over the last three months.

How Many Shares Of CDNA Are Available?

Traders seem to like to know the amounts of shares both available and outstanding. In regard to CareDx, Inc, currently there are 41.78M and there is a float of 37.38M. This means that out of the total of 41.78M shares of CDNA that are out there today, 37.38M are able to trade hands on the public market.

I also like to look at the short percentage of the float. Think about it, if a high percentage of the float is sold short, the overall feeling in the market is that the company is going to fall hard. When it comes to CDNA, the short percentage of the float is currently 6.58%. Most investors would say that a concerning short percent of the float is any percentage over 40%. Through my work, I have calculated that any short percent of the float over 26% is likely a a play that could prove to be very risky.

What We’ve Seen Over The Past Year?

The past year has been an exciting one for CareDx, Inc. Throughout the past 52 weeks, the stock has traded cleanly in the range between $5.51 – 32.65. Considering the range, the current price of CDNA sits at 515.97% of its 52 week low and 3.95% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to 0.22 with the company generating revenue of 65.60M in the period.

What You Need To Know About Earnings

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0.16. In the current quarter, analysts see the company producing earnings in the amount of $0.00. Over the last 5 years, CDNA has generated revenue in the amount of $18.80% with earnings coming in at 16.50%. On a quarter over quarter basis, earnings have seen movement of 15.10% and revenue has seen movement of 73.80%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can look through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you would to teach me something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, leave a comment below and I will use it to serve you better!

Mar-07-19 04:53PM Top-Rated Medical Stock Rockets After Turning A Profit A Quarter Early
04:43PM Edited Transcript of CDNA earnings conference call or presentation 6-Mar-19 9:30pm GMT
03:46PM Here’s Why CareDX Is on the Move Today
Mar-06-19 08:04PM CareDx Inc (CDNA) Q4 2018 Earnings Conference Call Transcript
04:01PM CareDx Reports Fourth Quarter and FY 2018 Results
Mar-05-19 08:00AM CareDx Welcomes Initiatives from US Government to Support Transplant Care
Feb-26-19 08:00AM CareDx to Participate in the Cowen and Company 39th Annual Health Care Conference
Feb-21-19 08:00AM AlloSure now available for Lung Transplant Patients
Feb-20-19 08:00AM CareDx Drives Personalized Medicine in Transplantation at CEOT
Feb-19-19 07:45AM Factors of Influence in 2019, Key Indicators and Opportunity within Sierra Wireless, United States Steel, CareDx, Cedar Fair, Unitil, and Cavco Industries New Research Emphasizes Economic Growth


Please enter your comment!
Please enter your name here